At its core Molecule's mission is to help biopharma researchers find resources and partners to conduct their research project. A recurring problem in early-stage biopharma research is the lack of funding and the time it takes to acquire such funding. There are several reasons for this but most boil down to non-standardised, complex legal agreements, missing access to investors, and alignment need of multiple stakeholders.
Molecule tackles these problems with its unique IP-NFT framework. Our team has a collection of standardized legal agreements that will be connected to non-fungible tokens, enabling any researcher to collect funding from existing early-stage investors. No legal entity, no external lawyers needed.